Synchro Motion is a cutting-edge startup that specializes in revolutionizing rehabilitation robotics through advanced control systems, aiming to enhance mobility and support. Their flagship products include the MPC ankle prosthesis, which incorporates controls for damping, stiffness, and repositioning, and the SSA prosthetic knee, featuring hydraulic stance control and active swing assistance. In addition, they offer a low-profile prosthetic foot designed for improved usability. Established in 2017, the company operates within the Health Care and Medical Devices industries. Notably, their recent milestone involved securing a $223.59K grant investment on 04 February 2019, with the National Science Foundation as the investors.
No recent news or press coverage available for Synchro Motion.